Résumé :
|
[BDSP. Notice produite par INIST-CNRS R0xB9Hnk. Diffusion soumise à autorisation]. In randomized trials, the effect of vitamin D supplementation on blood pressure has been equivocal, while most prospective cohort studies have shown that the risk of incident hypertension is lower in people with higher levels of 25-hydroxyvitamin D (25 (OH) D). The authors examined the association between levels of 25 (OH) D and changes in blood pressure and incident hypertension in 4,863 postmenopausal women recruited into the Women's Health Initiative between 1993 and 1998. Over 7 years, there were no significant differences in the adjusted mean change in systolic or diastolic blood pressure by quartile of 25 (OH) D. The covariate-adjusted risk of incident hypertension was slightly lower in the upper 3 quartiles of 25 (OH) D compared with the lowest quartile, but this was statistically significant only in the third quartile (hazard ratio =0.67,95 % confidence interval : 0.46,0.96). There was no significant linear or nonlinear trend in the risk of incident hypertension by untransformed or log-transformed continuous values of 25 (OH) D. In postmenopausal women in this study, serum levels of 25 (OH) D were not related to changes in blood pressure, and evidence for an association with lower risk of incident hypertension was weak.
|